Cureus

Urgent Care.

With its innovative business model, Cureus solves the challenge of open access OA publishing of peer-reviewed articles by medical professionals without access to research grant funds. Founded in Silicon Valley in , Cureus has designed a unique, highly efficient, OA publishing platform. Well-drafted, relevant and credible submissions are published for free following peer review. Cureus has established itself as a leader within the Open Access publishing movement with a philosophy emphasizing scientific credibility over perceived impact. This has resulted in over 32, articles published to date as well as a growing monthly audience of over one million unique readers contributing over three million monthly article views.

Cureus

Cureus: Journal of Medical Science is a web-based peer-reviewed open access general medical journal using prepublication peer review. It is also the first academic journal which provides authors with step-by-step templates for them to use to write their papers. The journal was originally started as PeerEMed in , obtaining its current name in December The journal is abstracted and indexed in the Emerging Sources Citation Index. Its peer-review process involves asking experts to review a given article in a few days, which results in its peer reviews taking much less time than those of most other journals do. We believe that post publication peer review, a focus of our journal through commenting and our unique SIQ process, is potentially a more powerful way to discern truth. A study conducted by librarians of Emory University found that Cureus was in the top 2 of institutional publications deemed predatory or untrustworthy. In April , Cureus displayed a Wall of Shame to "highlight authors who have committed egregious ethical violations as well as the institutions that enabled them". This feature was withdrawn in May In January , 56 papers were retracted. Contents move to sidebar hide. Article Talk. Read Edit View history. Tools Tools.

Consider your research goals, cureus, target audience, and the specific requirements of your field when choosing the right journal for your work.

A journal is retracting a paper on the purported harms of vaccines against COVID written in part by authors who have had similar work retracted before. It has appeared frequently in these pages. I can confirm we will be retracting it by the end of the week, as we have provided the authors with a deadline to reply and indicate whether they agree or disagree with the retraction. The journal Cureus has retracted 56 papers nearly two years after it first began to suspect the works were of dubious lineage. Cureus — an open access journal founded in and acquired by Springer Nature in — slapped 55 of the papers with expressions of concern in April This week, the journal retracted 56 studies.

With its innovative business model, Cureus solves the challenge of open access OA publishing of peer-reviewed articles by medical professionals without access to research grant funds. Founded in Silicon Valley in , Cureus has designed a unique, highly efficient, OA publishing platform. Well-drafted, relevant and credible submissions are published for free following peer review. Cureus has established itself as a leader within the Open Access publishing movement with a philosophy emphasizing scientific credibility over perceived impact. This has resulted in over 32, articles published to date as well as a growing monthly audience of over one million unique readers contributing over three million monthly article views.

Cureus

Our understanding of COVID vaccinations and their impact on health and mortality has evolved substantially since the first vaccine rollouts. In the interim, problems with the methods, execution, and reporting of these pivotal trials have emerged. Re-analysis of the Pfizer trial data identified statistically significant increases in serious adverse events SAEs in the vaccine group. Numerous SAEs were identified following the Emergency Use Authorization EUA , including death, cancer, cardiac events, and various autoimmune, hematological, reproductive, and neurological disorders. Furthermore, these products never underwent adequate safety and toxicological testing in accordance with previously established scientific standards. Among the other major topics addressed in this narrative review are the published analyses of serious harms to humans, quality control issues and process-related impurities, mechanisms underlying adverse events AEs , the immunologic basis for vaccine inefficacy, and concerning mortality trends based on the registrational trial data.

Bose soundtrue ultra

Impact factor. To that list we hesitatingly add Ahmed Elkhouly and his spouse. All Press Releases. Is Cureus A Good Journal? The journal is abstracted and indexed in the Emerging Sources Citation Index. Consider your research goals, target audience, and the specific requirements of your field when choosing the right journal for your work. Q: Can I include supplementary materials with my article in Cureus? Stretch your horizons. Corporate Responsibility Taking Responsibility. Full Disclaimer. The fate of articles — both by authors in the United Kingdom — highlight the precariousness of papers that rely on consent from patients or, in one instance, their proxies. That might be true, but evidently the article did a poor job of making the argument.

Federal government websites often end in.

This feature was withdrawn in May Multimedia Integration : Cureus allows authors to incorporate multimedia elements such as images, videos, and interactive figures into their articles. Contents move to sidebar hide. The journal aims to reduce the time from submission to publication, ensuring that your work reaches the medical community promptly. Follow us on Twitter Here to foster information exchange with the library community. The journal Cureus has retracted 56 papers nearly two years after it first began to suspect the works were of dubious lineage. I am confident that together we can accelerate Cureus' mission to eliminate publishing barriers for new medical knowledge and create an entirely new category of healthcare network. Not all submissions are accepted for publication, and the journal maintains certain criteria for article selection. Publishing in Cureus offers several advantages, including open access, rapid publication, multimedia integration, and post-publication peer review. What is Cureus? Our Communities. Hidden categories: Articles with short description Short description is different from Wikidata Irregular journals infobox Wikipedia articles needing clarification from February However, it is recommended to review the journal's submission guidelines for specific requirements. A: Yes, Cureus allows authors to include supplementary materials to support their research. Good luck with your publishing journey!